Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:569-574

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Litchfield, W. R.
Right arrow Articles by Williams, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Litchfield, W. R.
Right arrow Articles by Williams, G. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*HYDROCORTISONE

(Hypertension. 1998;31:569-574.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Increased Urinary Free Cortisol

A Potential Intermediate Phenotype of Essential Hypertension

W. Reid Litchfield; Steven C. Hunt; Xavier Jeunemaitre; Naomi D. L. Fisher; Paul N. Hopkins; Roger R. Williams; Pierre Corvol; ; Gordon H. Williams

From the Department of Medicine (W.R.L., N.D.L.F., G.H.W.), Brigham and Women's Hospital and Harvard Medical School, Boston, Mass; the Department of Medicine (S.H., P.H., R.W.), University of Utah, Salt Lake City, Utah; and the Department of Molecular Hypertension and Clinical Investigative Center (X.J., P.C.), Hospital Broussais, Paris, France.

Abstract—We evaluated urinary cortisol excretion as a potential intermediate phenotype of essential hypertension in 153 white patients with essential hypertension and 18 normotensive white control subjects. Analyses were controlled for dietary sodium and gender to adjust for potential confounding effects of these variables on cortisol excretion. Urinary cortisol excretion measured on both high- and low-salt diets was significantly related to hypertension by repeated measures ANCOVA (P=.02). Additional determinants of urinary free cortisol included dietary sodium intake and gender; cortisol excretion was significantly higher in men (P=.0006) and during a high-sodium diet (P=.0001). Maximum likelihood analysis showed urinary cortisol to have a bimodal distribution on both 200-mmol (P<.01) and 10-mmol (P<.002) sodium diets in hypertensive subjects. On the low-salt diet, the mean urinary cortisol in normotensive subjects (108.7±44.7 nmol/d) was similar to the mean of hypertensive subjects in the low mode (127.2±43.0 nmol/d). The high mode comprised 31.2% of the hypertensive population and had a mean urinary cortisol of 224.3±93.8 nmol/d. Subjects with the highest urinary free cortisol showed the least sensitivity of blood pressure to dietary sodium loading (P<.05). These data suggest that there is an association between salt-resistant hypertension and high urine cortisol levels. This association may have a genetic basis.


Key Words: cortisol • genetics • phenotype, intermediate • sodium • bimodality




This article has been cited by other articles:


Home page
Psychosom. Med.Home page
G. J. Molloy, L. Perkins-Porras, P. C. Strike, and A. Steptoe
Type-D Personality and Cortisol in Survivors of Acute Coronary Syndrome
Psychosom Med, October 1, 2008; 70(8): 863 - 868.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
V. F. Panoulas, G. S. Metsios, A. V. Pace, H. John, G. J. Treharne, M. J. Banks, and G. D. Kitas
Hypertension in rheumatoid arthritis
Rheumatology, September 1, 2008; 47(9): 1286 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
V. F. Panoulas, K. M. J. Douglas, A. Stavropoulos-Kalinoglou, G. S. Metsios, P. Nightingale, M. D. Kita, M. S. Elisaf, and G. D. Kitas
Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis
Rheumatology, January 1, 2008; 47(1): 72 - 75.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A L Markel, O E Redina, M A Gilinsky, G M Dymshits, E V Kalashnikova, Y. V Khvorostova, L A Fedoseeva, and G S Jacobson
Neuroendocrine profiling in inherited stress-induced arterial hypertension rat strain with stress-sensitive arterial hypertension
J. Endocrinol., December 1, 2007; 195(3): 439 - 450.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Pecori Giraldi, A. G. Ambrogio, M. De Martin, L. M. Fatti, M. Scacchi, and F. Cavagnini
Specificity of First-Line Tests for the Diagnosis of Cushing's Syndrome: Assessment in a Large Series
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4123 - 4129.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Chamarthi, N. S. Kolatkar, S. C. Hunt, J. S. Williams, E. W. Seely, N. J. Brown, L. J. Murphey, X. Jeunemaitre, and G. H. Williams
Urinary Free Cortisol: An Intermediate Phenotype and a Potential Genetic Marker for a Salt-Resistant Subset of Essential Hypertension
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1340 - 1346.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. G. Bechtold and D. A. Scheuer
Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1003 - R1011.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. al'Absi, C. France, A. Harju, J. France, and L. Wittmers
Adrenocortical and nociceptive responses to opioid blockade in hypertension-prone men and women.
Psychosom Med, March 1, 2006; 68(2): 292 - 298.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. M. Kurina, L. A. Weiss, S. W. Graves, R. Parry, G. H. Williams, M. Abney, and C. Ober
Sex Differences in the Genetic Basis of Morning Serum Cortisol Levels: Genome-Wide Screen Identifies Two Novel Loci Specific to Women
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4747 - 4752.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. M. Masi, E. M. Rickett, L. C. Hawkley, and J. T. Cacioppo
Gender and ethnic differences in urinary stress hormones: the population-based Chicago Health, Aging, and Social Relations Study
J Appl Physiol, September 1, 2004; 97(3): 941 - 947.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Bocchi, S. Kenouch, M. Lamarre-Cliche, M. Muffat-Joly, M. H. Capron, J. Fiet, G. Morineau, M. Azizi, J. P. Bonvalet, and N. Farman
Impaired 11-{beta} Hydroxysteroid Dehydrogenase Type 2 Activity in Sweat Gland Ducts in Human Essential Hypertension
Hypertension, April 1, 2004; 43(4): 803 - 808.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Moreno, P. Dumas, M. L. Kaldunski, P. J. Tonellato, A. S. Greene, R. J. Roman, Q. Cheng, Z. Wang, H. J. Jacob, and A. W. Cowley Jr
Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats
Physiol Genomics, November 11, 2003; 15(3): 243 - 257.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. N. Kerstens, F. G. H. van der Kleij, A. H. Boonstra, W. J. Sluiter, J. Koerts, G. Navis, and R. P. F. Dullaart
Salt Loading Affects Cortisol Metabolism in Normotensive Subjects: Relationships with Salt Sensitivity
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4180 - 4185.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. D.L. Fisher, S. Hurwitz, X. Jeunemaitre, D. A. Price, G. H. Williams, and N. K. Hollenberg
Adrenal Response to Angiotensin II in Black Hypertension: Lack of Sexual Dimorphism
Hypertension, September 1, 2001; 38(3): 373 - 378.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. A. Whitworth, G. J. Mangos, and J. J. Kelly
Cushing, Cortisol, and Cardiovascular Disease
Hypertension, November 1, 2000; 36(5): 912 - 916.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. C. Y. Lin, W. Y. S. Wang, and B. J. Morris
Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension
Hypertension, December 1, 1999; 34(6): 1186 - 1192.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. C. Inglis, M. C. Ingram, C. D. Holloway, L. Swan, D. Birnie, W. S. Hillis, E. Davies, R. Fraser, and J. M. C. Connell
Familial Pattern of Corticosteroids and Their Metabolism in Adult Human Subjects - the Scottish Adult Twin Study
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4132 - 4137.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Lovati, P. Ferrari, B. Dick, K. Jostarndt, B. M. Frey, F. J. Frey, U. Schorr, and A. M. Sharma
Molecular Basis of Human Salt Sensitivity: The Role of the 11{beta}-Hydroxysteroid Dehydrogenase Type 2
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3745 - 3749.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. H. Pratt, J. F. Rebhun, L. Zhou, W. T. Ambrosius, S. A. Newman, C. E. Gomez-Sanchez, and D. F. Mayes
Levels of Mineralocorticoids in Whites and Blacks
Hypertension, August 1, 1999; 34(2): 315 - 319.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Fraser, M. C. Ingram, N. H. Anderson, C. Morrison, E. Davies, and J. M. C. Connell
Cortisol Effects on Body Mass, Blood Pressure, and Cholesterol in the General Population
Hypertension, June 1, 1999; 33(6): 1364 - 1368.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Davies, C. D. Holloway, M. C. Ingram, G. C. Inglis, E. C. Friel, C. Morrison, N. H. Anderson, R. Fraser, and J. M. C. Connell
Aldosterone Excretion Rate and Blood Pressure in Essential Hypertension Are Related to Polymorphic Differences in the Aldosterone Synthase Gene CYP11B2
Hypertension, February 1, 1999; 33(2): 703 - 707.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Horiguchi, M. Kimura, J. Skurnick, and A. Aviv
Parameters of Lymphocyte Na+-Ca2+ Regulation and Blood Pressure : The Gender Effect
Hypertension, November 1, 1998; 32(5): 869 - 874.
[Abstract] [Full Text] [PDF]